{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:59:27Z","timestamp":1785340767022,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejpb.2026.115121","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:27:14Z","timestamp":1779676034000},"page":"115121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["QbD-based intranasal pH-sensitive Ibrutinib liposomes for glioblastoma management: in vitro, ex vivo, and in vivo pharmacokinetics and brain distribution assessment"],"prefix":"10.1016","volume":"225","author":[{"given":"Anupama","family":"Sikder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Naresh Katarpawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Phatale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vambhurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giriraj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Wagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etikala","family":"Amulya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khairnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol G.","family":"Dikundwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-4363","authenticated-orcid":false,"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115121_b0005","unstructured":"F. Hanif, K. Muzaffar, \u2026 K.P.-A.P. journal, undefined 2017, Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment, Pmc.Ncbi.Nlm.Nih.Gov (n.d.). https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5563115\/ (accessed August 1, 2025)."},{"key":"10.1016\/j.ejpb.2026.115121_b0010","article-title":"Deciphering convection enhanced delivery: a paradigm shift for circumventing glioblastoma multiforme","volume":"103","author":"Sikder","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115121_b0015","article-title":"Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma","volume":"15","author":"Scorsetti","year":"2015","journal-title":"Springer"},{"key":"10.1016\/j.ejpb.2026.115121_b0020","unstructured":"C. Arvanitis, G. Ferraro, R.J.-N.R. Cancer, undefined 2020, The blood\u2013brain barrier and blood\u2013tumour barrier in brain tumours and metastases, Nature.Com (n.d.). https:\/\/www.nature.com\/articles\/s41568-019-0205-x (accessed August 1, 2025)."},{"key":"10.1016\/j.ejpb.2026.115121_b0025","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3390\/curroncol31070296","article-title":"Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme\u2014A Literature Review and Clinical Outcomes","volume":"31","author":"Jezierza\u0144ski","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejpb.2026.115121_b0030","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"17","author":"Singh","year":"2021","journal-title":"Cancer Drug Resistance 4"},{"key":"10.1016\/j.ejpb.2026.115121_b0035","article-title":"Navigating the brain: Harnessing endogenous cellular hitchhiking for targeting neoplastic and neuroinflammatory diseases","volume":"20","author":"Wagh","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115121_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126077","article-title":"Nano-biohybrids with cell-penetrating peptides: a molecular trojans for glioblastoma precision medicine","volume":"683","author":"Phatale","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.drudis.2019.10.005","article-title":"Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook","volume":"25","author":"Sabir","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2026.115121_b0050","first-page":"957","article-title":"Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood\u2013brain barrier: an excellent platform for brain targeting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Taylor & Francis"},{"key":"10.1016\/j.ejpb.2026.115121_b0055","doi-asserted-by":"crossref","unstructured":"M. Abrami, A. Biasin, F. Tescione, D. Tierno, B. Dapas, A. Carbone, G. Grassi, M. Conese, S. Di Gioia, D. Larobina, M. Grassi, Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases, International Journal of Molecular Sciences 2024, Vol. 25, Page 1933. 10.3390\/IJMS25031933.","DOI":"10.3390\/ijms25031933"},{"key":"10.1016\/j.ejpb.2026.115121_b0060","doi-asserted-by":"crossref","unstructured":"M. Boegh, & H.N.-B.& clinical pharmacology, undefined 2015, Mucus as a barrier to drug delivery\u2013understanding and mimicking the barrier properties, Wiley Online Library 116 (2015) 179\u2013186. 10.1111\/BCPT.12342.","DOI":"10.1111\/bcpt.12342"},{"key":"10.1016\/j.ejpb.2026.115121_b0065","doi-asserted-by":"crossref","unstructured":"S. Islam, A. Shehzad, M. Ahmed, Y.L.- Molecules, undefined 2020, Intranasal delivery of nanoformulations: a potential way of treatment for neurological disorders, Mdpi.Com (n.d.). https:\/\/www.mdpi.com\/1420-3049\/25\/8\/1929 (accessed August 5, 2025).","DOI":"10.3390\/molecules25081929"},{"key":"10.1016\/j.ejpb.2026.115121_b0070","first-page":"1372","article-title":"A Review of Liposomes as a Drug delivery System: Current Status of Approved Products","volume":"27","author":"Liu","year":"2022","journal-title":"Regulatory Environments, and Future Perspectives, Molecules"},{"key":"10.1016\/j.ejpb.2026.115121_b0075","doi-asserted-by":"crossref","unstructured":"C. Spuch, C.N.-J. of drug delivery, undefined 2011, Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer\u2032 s Disease and Parkinson\u2032 s Disease), Wiley Online Library 2011 (2011) 1\u201312. 10.1155\/2011\/469679.","DOI":"10.1155\/2011\/469679"},{"key":"10.1016\/j.ejpb.2026.115121_b0080","first-page":"696","article-title":"pH\u2010Sensitive stimulus\u2010responsive nanocarriers for targeted delivery of therapeutic agents, Wiley Online","volume":"8","author":"Karimi","year":"2016","journal-title":"Library"},{"key":"10.1016\/j.ejpb.2026.115121_b0085","unstructured":"T. Wen, J. Wang, Y. Shi, H. Qian, P.L.- Leukemia, undefined 2021, Inhibitors targeting Bruton\u2019s tyrosine kinase in cancers: drug development advances, Nature.Com (n.d.). https:\/\/www.nature.com\/articles\/s41375-020-01072-6 (accessed August 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115121_b0090","first-page":"3784","article-title":"Unleashing the potential of Ibrutinib-Loaded Nanoparticles for Cancer Treatment\u2014A Comprehensive Review","volume":"14","author":"Behzadmehr","year":"2024","journal-title":"Springer"},{"key":"10.1016\/j.ejpb.2026.115121_b0095","doi-asserted-by":"crossref","unstructured":"B. Morshedi, M. Esfandyari-Manesh, F. Atyabi, M. Hossein Ghahremani, R. Dinarvand, M. esfandyari-Manesh, F. atyabi, M. hossein Ghahremani, Local delivery of ibrutinib by folate receptor-mediated targeting PLGA\u2013PEG nanoparticles to glioblastoma multiform: in vitro and in vivo studies, J. Drug Target. 33 (2025) 1026\u20131041. 10.1080\/1061186X.2025.2468749.","DOI":"10.1080\/1061186X.2025.2468749"},{"key":"10.1016\/j.ejpb.2026.115121_b0100","doi-asserted-by":"crossref","DOI":"10.2174\/0113816128378420250804145740","article-title":"Ibrutinib Loaded Nanostructured Lipid Carriers for the Management of Chronic Lymphocytic Leukemia: Synchronizing In Silico, In Vitro, and In Vivo Studies","volume":"31","author":"Patel","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2026.115121_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122436","article-title":"Co-delivery of ibrutinib and hydroxychloroquine by albumin nanoparticles for enhanced chemotherapy of glioma","volume":"630","author":"Yang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0110","first-page":"1623","article-title":"Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy","volume":"20","author":"Chen","year":"2023","journal-title":"Taylor & Francis"},{"key":"10.1016\/j.ejpb.2026.115121_b0115","article-title":"Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis","volume":"68","author":"Jain","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115121_b0120","doi-asserted-by":"crossref","unstructured":"J.E.-M. validation in pharmaceutical analysis: a, undefined 2025, ICH Q2 (R2): validation of analytical procedures, Wiley Online LibraryJ ErmerMethod Validation in Pharmaceutical Analysis: A Guide to Best Practice, 2025\u2022Wiley Online Library (2025) 351\u2013372. 10.1002\/9783527831708.CH13.","DOI":"10.1002\/9783527831708.ch13"},{"key":"10.1016\/j.ejpb.2026.115121_b0125","unstructured":"I.G.- Q9, C. step, undefined 2005, Quality risk management, Pharmatech.NlICHHT GuidelineQ9, Current Step, 2005\u2022pharmatech.Nl (2005). https:\/\/www.pharmatech.nl\/pdf\/part3\/quality_risk_management_en.pdf (accessed April 29, 2026)."},{"key":"10.1016\/j.ejpb.2026.115121_b0130","unstructured":"I.G.-Q. (2R). A. revised in August, undefined 2009, Pharmaceutical development, Aktinchem.ComICHHT GuidelineQ8 (2R). As Revised in August, 2009\u2022aktinchem.Com (2009). https:\/\/www.aktinchem.com\/u_file\/download\/23_12_18\/47b77bea10.pdf (accessed April 29, 2026)."},{"key":"10.1016\/j.ejpb.2026.115121_b0135","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.3390\/pharmaceutics14122742","article-title":"Lipid and Polymeric Nanoparticles: successful strategies for Nose-to-Brain Drug delivery in the Treatment of Depression and anxiety Disorders","volume":"14","author":"Alberto","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115121_b0140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/ph18050615","article-title":"Advancements in Nanocarrier Systems for Nose-to-Brain Drug Delivery","volume":"18","author":"Nguyen","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115121_b0145","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2022.09.024","article-title":"Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation","volume":"180","author":"Shah","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0150","first-page":"1476","article-title":"QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach, Drug Deliv","volume":"10","author":"Rangaraj","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115121_b0155","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/03639045.2025.2509861","article-title":"Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticles","volume":"51","author":"Jain","year":"2025","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/bio.70372","article-title":"Development and Characterization of Sensitive, Eco-Friendly, and Selective Microwave-aided Fluorodensitometric Probe for Estimation of Alfuzosin using Comprehensive Approach of Multicolored Analytical Chemistry and Design of Experiments","volume":"40","author":"Prajapati","year":"2025","journal-title":"Luminescence"},{"key":"10.1016\/j.ejpb.2026.115121_b0165","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/08982104.2025.2573681","article-title":"Comparative in-vivo and in-vitro characterization of Donepezil loaded Lactoferrin linked PEG coated and uncoated nanocarriers as intranasal drugdelivery system","volume":"35","author":"Prajapati","year":"2025","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2026.115121_b0170","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.70157","article-title":"Integrated Approach of Risk-based Quality by Design and Multicolored Sustainable Analytical Chemistry to Stability-Indicating Chromatographic Method for concurrent Analysis of Sitagliptin and Glimepiride","volume":"8","author":"Prajapati","year":"2025","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.ejpb.2026.115121_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/chromsci\/bmaf051","article-title":"Harmonized Approach of Design of Experiments with Green and White Analytical Chemistry in Unified Framework for Synchronous Chromatographic Assay of Diverse Combinations of Anti-diabetic Drugs in Pharmaceutical Dosage Forms","volume":"63","author":"Prajapati","year":"2025","journal-title":"J. Chromatogr. Sci."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115121_b0180","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1007\/s10895-025-04518-1","article-title":"Hybrid Principles of RGB12 and QbD to Photoinduced Electron transfer Mechanism based Sensitive and Green Nano-scale Spectrofluorimetric Insights for Estimation of Brucine","volume":"35","author":"Prajapati","year":"2025","journal-title":"J. Fluoresc."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115121_b0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12247-026-10373-9","article-title":"Sensitive and Selective Fluorescent Mannich Adduct Biosensing Probe for Estimation of Carvedilol using Integrated Approach of White Analytical Chemistry and Quality by Design","volume":"21","author":"Prajapati","year":"2026","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2026.115121_b0190","article-title":"Quality by design enabled tumor microenvironment-responsive simvastatin-loaded liposomes for prostate cancer management","volume":"94","author":"Shahrukh","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115121_b0195","doi-asserted-by":"crossref","first-page":"79-","DOI":"10.1007\/s10876-026-03026-x","article-title":"Quality by Design Manoeuvred Cabazitaxel-Loaded Polycaprolactone Nanoparticles for Management of Melanoma: Development, Optimization, In Silico Modeling and In Vitro Studies","volume":"37","author":"Wagh","year":"2026","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.ejpb.2026.115121_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112501","article-title":"Doxorubicin Loaded Thermosensitive Magneto-Liposomes Obtained by a Gel Hydration Technique: Characterization and In Vitro Magneto-Chemotherapeutic effect Assessment","volume":"14","author":"Nitica","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115121_b0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40005-019-00458-8","article-title":"Encapsulation and physicochemical evaluation of efavirenz in liposomes","volume":"50","author":"Okafor","year":"2019","journal-title":"J. Pharm. Investig."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115121_b0210","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s10973-017-6394-1","article-title":"DSC for evaluating the encapsulation efficiency of lidocaine-loaded liposomes compared to the ultracentrifugation method","volume":"130","author":"Bakonyi","year":"2017","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejpb.2026.115121_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121563","article-title":"Stanis\u00e7uaski Guterres, Nose-to-brain delivery of simvastatin mediated by chitosan-coated lipid-core nanocapsules allows for the treatment of glioblastoma in vivo","volume":"616","author":"Bruinsmann","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115121_b0220","doi-asserted-by":"crossref","first-page":"221-","DOI":"10.1007\/s12668-025-01833-6","article-title":"QbD Manoeuvred Niclosamide Laden Polylactic-co-Glycolic Acid Nanoparticles-Impregnated Gelatin Nanofibers for the Management of Oral Carcinoma","volume":"15","author":"Shah","year":"2025","journal-title":"BioNanoScience"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115121_b0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s12668-025-02153-5","article-title":"Disulfiram-Encapsulated Poly(caprolactone) Nanofiber Scaffolds for Oral Squamous Cell Carcinoma Management","volume":"15","author":"Pandey","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.ejpb.2026.115121_b0230","article-title":"Enhanced bioavailability and therapeutic efficacy of Ibrutinib and naringenin-loaded self-nanoemulsifying drug delivery system","volume":"109","author":"Jati","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115121_b0235","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/03639045.2025.2453533","article-title":"Docetaxel and niclosamide-loaded nanofiber systems for improved chemo-therapeutic activity and resistance reversal in prostate cancer, Drug Dev","volume":"51","author":"Shah","year":"2025","journal-title":"Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0240","article-title":"Smart chlorotoxin-functionalized liposomes for sunitinib targeted delivery into glioblastoma cells","volume":"77","author":"Charkhat Gorgich","year":"2022","journal-title":"J. Drug Deliv Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115121_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejpb.2026.115121_b0250","doi-asserted-by":"crossref","unstructured":"S. Shaikh, P.S. Chary, O. Khan, N.K. Mehra, Development and evaluation of nilotinib-loaded Bovine Serum Albumin nanoparticles: In-vitro and in-silico insights, ElsevierS Shaikh, PS Chary, O Khan, NK MehraInternational Journal of Biological Macromolecules, 2025\u2022Elsevier 308 (2025). 10.1016\/j.ijbiomac.2025.142185.","DOI":"10.1016\/j.ijbiomac.2025.142185"},{"key":"10.1016\/j.ejpb.2026.115121_b0255","first-page":"2239","article-title":"Role of three-dimensional cell culture in therapeutics and diagnostics: an updated review, Drug Deliv","volume":"13","author":"Biju","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115121_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2024.1491669","article-title":"Perspective of 3D culture in medicine: transforming disease research and therapeutic applications","volume":"12","author":"Park","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115121_b0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.actbio.2020.06.019","article-title":"Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy","volume":"113","author":"Barve","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115121_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141136","article-title":"Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in A\u03b21\u201342 induced C57BL\/6 mice for Alzheimer\u2019s disease treatment","volume":"305","author":"Prabakaran","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115121_b0275","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jssc.202100452","article-title":"Homogeneous liquid\u2013liquid extraction as an alternative sample preparation technique for biomedical analysis","volume":"45","author":"Hammad","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.ejpb.2026.115121_b0280","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10337-024-04332-0","article-title":"Simultaneous Determination and Drug\u2013Drug Interaction Study of Losartan and Aprepitant through Pharmacokinetic Approach in Rat Plasma by UHPLC\u2013QqQ-MS\/MS","volume":"87","author":"Katarpawar","year":"2024","journal-title":"Chromatographia"},{"key":"10.1016\/j.ejpb.2026.115121_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119499","article-title":"Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting","volume":"586","author":"Kumbhar","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115121_b0290","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/pharmaceutics13071071","article-title":"An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development","volume":"13","author":"N\u00e9meth","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115121_b0295","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jpba.2015.10.033","article-title":"Liquid chromatography\u2013tandem mass spectrometric assay for the simultaneous determination of the irreversible BTK inhibitor ibrutinib and its dihydrodiol-metabolite in plasma and its application in mouse pharmacokinetic studies","volume":"118","author":"Rood","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115121_b0300","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.5958\/0974-360X.2018.00839.9","article-title":"A sensitive stability indicating RP-HPLC method for the determination of Ibrutinib - an anti-cancer drug","volume":"11","author":"Bindu","year":"2018","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.ejpb.2026.115121_b0305","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.3390\/molecules27154766","article-title":"A High-Throughput Clinical Laboratory Methodology for the Therapeutic monitoring of Ibrutinib and Dihydrodiol Ibrutinib","volume":"27","author":"Karvaly","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115121_b0310","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/22297928.2019.1673814","article-title":"Development and Validation of a Stability-indicating Method for Ibrutinib: Identification and Separation of Degradation Products, known and Genotoxic Impurities using RP-HPLC\/PDA and QDa Mass Detectors","volume":"10","author":"Konduru","year":"2020","journal-title":"Anal. Chem. Lett."},{"key":"10.1016\/j.ejpb.2026.115121_b0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11533-1","article-title":"Formation and purification of tailored liposomes for drug delivery using a module-based micro continuous-flow system","author":"Dimov","year":"2017","journal-title":"Scientific Reports 7"},{"key":"10.1016\/j.ejpb.2026.115121_b0320","doi-asserted-by":"crossref","first-page":"36349","DOI":"10.1038\/s41598-025-20144-0","article-title":"pH-triggered liposomal strategy for cisplatin in lung cancer therapy","volume":"15","author":"Demirbolat","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2026.115121_b0325","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.colsurfb.2018.11.025","article-title":"Lamotrigine encapsulated intra-nasal nanoliposome formulation for epilepsy treatment: Formulation design, characterization and nasal toxicity study","volume":"174","author":"Praveen","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:21:16Z","timestamp":1781234476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":65,"alternative-id":["S0939641126001426"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115121","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QbD-based intranasal pH-sensitive Ibrutinib liposomes for glioblastoma management: in vitro, ex vivo, and in vivo pharmacokinetics and brain distribution assessment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115121"}}